Brief: Theravance Biopharma Announces Tender Offer For Outstanding 3.25% Convertible Senior Notes Due 2023
26/07/2022 13:59
July 26 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA ANNOUNCES TENDER OFFER FOR
OUTSTANDING
3.25% CONVERTIBLE SENIOR NOTES DUE 2023
Source text for Eikon: ID:nPn8VQfRca
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy